Tags Avidity Biosciences Novartis CEO Signals Bold M&A Plans Following $12 Billion Avidity Biosciences Deal businessx October 28, 2025 Novartis is making waves in the pharmaceutical industry with its latest move to acquire Avidity Biosciences for approximately $12 billion,
